Biocon’s API facility at Hyderabad Concludes USFDA Inspection, with Zero Observations

NOTIFICATION TO STOCK EXCHANGE

COMPANY STATEMENT

Telangana, Hyderabad, India, May 20, 2023

This is to inform you that the U.S. FDA concluded a pre-approval inspection for Site 3, Biocon Limited, located at Hyderabad, Telangana, on 19 May 2023, with no observations.